Delivery Order SPE2DB22D3004-SPE2DB25FQT44

Award Date 5/19/25
Potential Completion Date 5/20/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 420 ml bottles of 1 gram/10 ml Sucralfate suspension, a medication used to treat peptic ulcers. The contract has a firm fixed price of $1,308.52 and a period of performance through May 5, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,730.56, is for the supply of Sucralfate 1 gm/10 ml suspension in 420 ml bottles. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,663,747 units of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. The contract has a firm fixed price of $1,649.74 and a completion date of September 4, 2024. This contract is not a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Sucralfate 1 GM/10 ML Suspension, a pharmaceutical product used for various medical treatments. The contract has a ceiling value of $2,364.87 and a period of performance through December 3, 2024. The contract is a firm-fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,339.50, is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. The contract has an ultimate completion date of October 30, 2023 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sucralfate 1 GM tablets, a medication used to treat digestive issues, with a ceiling value of $10,616.12. The contract has a firm fixed price pricing type and a period of performance through May 17, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) the...
The federal contract award is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $1,455.06 with a Firm Fixed Price pricing type. The period of performance runs through May 16, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,273.83 firm fixed-price delivery order is for the supply of 90 tablets of the drug Sucralfate 1 GM. The contract has a performance period through May 20, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,590.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. No set-aside designation was used for this contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,044.82, is for the delivery of 420 ml bottles of 1 gram/10 ml sucralfate suspension. The award has an ultimate completion date of March 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQT44
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sucralfate 1 GM/10 ML Suspension 473 ML, a medication used to treat certain stomach and esophageal conditions. The contract has a firm fixed price of $1,595.74 and a completion date of May 20, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract supports the federal government's medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/24/25, 1:09 AM